← Open Payments lookup

SARAH LAND: Open Payments

NPI 1700956406 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$112,589 in 335 payments from 16 companies in 2025. Trend: 2023 $49,094 · 2024 $50,175 · 2025 $112,589

Speaker / faculty: $91,225Consulting: $12,250Food & beverage: $5,351Travel & lodging: $3,738Education: $26
CompanyPaymentsAmount
ABBVIE INC.62$41,642
Otsuka America Pharmaceutical, Inc.42$30,926
E.R. Squibb & Sons, L.L.C.38$19,282
Alkermes, Inc.52$18,564
Vanda Pharmaceuticals Inc.34$430
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$414
Corium, LLC21$244
Supernus Pharmaceuticals, Inc.15$241
Neurocrine BioSciences, Inc.17$235
Janssen Pharmaceuticals, Inc14$230

Products named: VRAYLAR, REXULTI, LYBALVI, COBENFY, ARISTADA, FANAPT, CAPLYTA, ABILIFY MAINTENA.

Industry payments across OK — which companies pay providers there.